Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

1352212

registered interest
date	03/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services: Refugees
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the availability of emergency dental treatment for refugees who have been resettled in the UK from Afghanistan as part of the UK's military withdrawal from that country.
tabling member constituency	Canterbury
tabling member printed	Rosie Duffield
uin	42068
answer	answer is ministerial correction date of answer 18/10/2021 answer text <p>Refugees, including those arriving from Afghanistan, can access emergency dental treatment via NHS 111.</p><p>Many individuals arriving from Afghanistan are doing so as part of the Afghanistan Relocation and Assistance Policy and Afghan Citizen’s Resettlement Scheme. A separate process applies in these cases, which includes linking with urgent care services. Where commissioners have made additional resources available this offer may be more comprehensive and include an enhanced health assessment.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 18/10/2021 13:07:01 answering member 4492 label Biography information for Maria Caulfield previous answer version 19506 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380
tabling member	4616 label Biography information for Rosie Duffield

1352312

registered interest
date	03/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Motor Neurone Disease: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 July 2021 to Question 35705 on Motor Neurone Disease: Drugs, if he will provide details of the projects relating to Motor Neurone Disease that were funded by the National Institute for Health Research in each of the years between 2015 and 2020.
tabling member constituency	Rochdale
tabling member printed	Tony Lloyd
uin	41672
answer	answer is ministerial correction date of answer 18/10/2021 answer text <p>The information requested is shown in the following table. The National Institute for Health Research (NIHR) is also funding research on motor neurone disease through the NIHR’s research infrastructure, including the NIHR Sheffield Biomedical Research Centre. However this information is not available at individual study level.</p><table><tbody><tr><td><p>Year</p></td><td><p>Project</p></td></tr><tr><td><p>2015/16</p></td><td><p>Telehealth in Motor Neurone Disease: the TiM trial. A randomised controlled pilot study of the use of the TiM system to deliver highly specialised care to patients and carers of those living with motor neurone disease. * Evaluation of the clinical and cost-effectiveness of Short-term Integrated Palliative Care Services (SIPC) to OPTimise CARE for people with advanced longterm Neurological conditions (OPTCARE Neuro) *</p></td></tr><tr><td><p>2016/17</p></td><td><p>Head up: The development of a novel cervical orthosis to support neck weakness due to neurological disease. * Telehealth in Motor Neurone Disease: the TiM trial. A randomised controlled pilot study of the use of the TiM system to deliver highly specialised care to patients and carers of those living with motor neurone disease. *<br> Evaluation of the clinical and cost-effectiveness of Short-term Integrated Palliative Care Services (SIPC) to OPTimise CARE for people with advanced longterm Neurological conditions (OPTCARE Neuro) *<br> DiPALS: A randomised controlled trial evaluating NeuRx/4 Diaphragm Pacing in patients with respiratory muscle weakness due to Motor Neurone Disease</p></td></tr><tr><td><p>2017/18</p></td><td><p>Telehealth in Motor Neurone Disease: the TiM trial. A randomised controlled pilot study of the use of the TiM system to deliver highly specialised care to patients and carers of those living with motor neurone disease. * Evaluation of the clinical and cost-effectiveness of Short-term Integrated Palliative Care Services (SIPC) to OPTimise CARE for people with advanced longterm Neurological conditions (OPTCARE Neuro) * A feasibility study and randomised controlled trial of acceptance and COMmitment therapy for people with Motor nEuroN Disease (COMMEND) *</p></td></tr><tr><td><p>2018/19</p></td><td><p>Telehealth in Motor Neurone Disease: the TiM trial. A randomised controlled pilot study of the use of the TiM system to deliver highly specialised care to patients and carers of those living with motor neurone disease. * A feasibility study and randomised controlled trial of acceptance and COMmitment therapy for people with Motor nEuroN Disease (COMMEND) * Nusinersen for treating infant or child spinal muscular atrophy [ID1069] A programme to develop and evaluate a complex intervention to achieve a high calorie diet for people with Amyotrophic Lateral Sclerosis (HighCALS) * Enhancing the efficacy of non-invasive ventilation for patients with motor neurone disease: Synthesising the evidence, mapping the services and translating the evidence into clinical practice. *</p></td></tr><tr><td><p>2019/20</p></td><td><p>A feasibility study and randomised controlled trial of acceptance and COMmitment therapy for people with Motor nEuroN Disease (COMMEND) * A programme to develop and evaluate a complex intervention to achieve a high calorie diet for people with Amyotrophic Lateral Sclerosis (HighCALS) * Enhancing the efficacy of non-invasive ventilation for patients with motor neurone disease: Synthesising the evidence, mapping the services and translating the evidence into clinical practice. * Onasemnogene abeparvovec for treating spinal muscular atrophy type 1 [ID1473] - Part 1</p></td></tr><tr><td><p>2020/21</p></td><td><p>A feasibility study and randomised controlled trial of acceptance and COMmitment therapy for people with Motor nEuroN Disease (COMMEND) * A programme to develop and evaluate a complex intervention to achieve a high calorie diet for people with Amyotrophic Lateral Sclerosis (HighCALS) * Enhancing the efficacy of non-invasive ventilation for patients with motor neurone disease: Synthesising the evidence, mapping the services and translating the evidence into clinical practice. * Onasemnogene abeparvovec for treating spinal muscular atrophy type 1[ID1473] - Part 2 Risdiplam for treating spinal muscular atrophy [ID1631]</p></td></tr></tbody></table><p><strong> </strong></p><p>Note:</p><p>* Project funded for multiple years spanning the period 2015-2020.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 18/10/2021 12:53:55 answering member 4492 label Biography information for Maria Caulfield
tabling member	450 label Biography information for Tony Lloyd

1352704

registered interest
date	03/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to improve awareness of ovarian cancer symptoms during Gynaecological Cancer Awareness Month in September.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	41791
answer	answer is ministerial correction date of answer 18/10/2021 answer text <p>While no specific ovarian cancer awareness campaigns were run as part of Gynaecological Cancer Awareness Month, NHS England and NHS Improvement and Public Health England launched the latest ‘Help us, help you’ campaign targeting abdominal symptoms of cancer in August 2021. This includes bloating or discomfort for three weeks or more, as this could be a sign of ovarian cancer.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 18/10/2021 12:49:44 answering member 4492 label Biography information for Maria Caulfield previous answer version 19500 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380
tabling member	1604 label Biography information for Mr Virendra Sharma

1349689

registered interest
date	22/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the levels of cancer diagnosis in (a) the Morley and Outwood constituency and (b) England.
tabling member constituency	Morley and Outwood
tabling member printed	Andrea Jenkyns
uin	38344
answer	answer is ministerial correction date of answer 18/10/2021 answer text <p>Between March 2020 and July 2021, there were 3.13 million urgent referrals and over 760,000 people receiving cancer treatment</p><p>West Yorkshire and Harrogate Cancer Alliance is leading on improving cancer diagnosis and outcomes for its local population, including Morley and Outwood. The Alliance is working with its local system to ensure that there is sufficient diagnostic and treatment capacity in place to meet cancer needs, introducing new pathways and initiatives including Rapid Diagnostic Centres (RDCs) and the Faster Diagnosis Standard. A new test to identify people at highest risk of oesophageal cancer is also being launched across West Yorkshire and Harrogate Cancer Alliance. Cytosponge can be swallowed in order to detect Barrett’s Oesophagus or pre-cancerous cells in the oesophagus, as a COVID-safe alternative to endoscopy.</p><p>Public Health England and NHS England and NHS Improvement are running a campaign, ’Help us help you’ to raise awareness of general symptoms of cancer and encourage people experiencing persistent symptoms to contact their general practitioner. in 2021/22 to tackle the elective backlog, from which cancer patients will benefit. This is being supported by £325 million of investment in National Health Service diagnostics. In July 2021, the NHS announced a further £20 million for Cancer Alliances to accelerate cancer diagnosis and enable management of high referral volumes. NHS England and NHS Improvement are prioritising delivery of NHS Long Term Plan commitments such as increasing diagnostic capacity and early diagnosis and survival rates through RDCs. As of June 2021, there were 102 RDCs across hospitals in England, compared to 12 in March 2020.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 18/10/2021 13:12:55 answering member 4492 label Biography information for Maria Caulfield
tabling member	4490 label Biography information for Dame Andrea Jenkyns

1349741

registered interest
date	22/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Yorkshire and the Humber
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the scale is of the cancer backlog (a) nationally, (b) in Yorkshire and (c) in York.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	38326
answer	answer is ministerial correction date of answer 18/10/2021 answer text <p>The information for Yorkshire and York is not held in the format requested. The number of people waiting longer than 62 days from an urgent referral for suspected cancer in England in July 2021, in the most recently published statistics, was approximately 18,000. This has reduced from 35,000 in May 2020.</p><p>The three Cancer Alliances in Yorkshire have worked with trusts and integrated care systems to ensure that cancer patients are prioritised and their care protected. Each system has developed comprehensive recovery plans to address backlogs and support the recovery in cancer including services such as screening and diagnostics. York and Scarborough Hospitals NHS Foundation Trust has worked to maintain cancer services throughout the pandemic and has continued to offer fast track and urgent diagnostics.</p><p>The Trust has prioritised bowel and breast cancer screening and is on target to offer breast screening to all eligible patients who missed routine screening. The Trust continues to work with the Cancer Alliance to reduce delays for patients by refreshing the cancer pathway analysers, targeting work on early diagnosis, including extending rapid diagnostic centres and appointing cancer pathway navigators in gynaecology, upper gastrointestinal and urology to support the timely diagnosis of patients.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 18/10/2021 13:03:50 answering member 4492 label Biography information for Maria Caulfield previous answer version 18940 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380
tabling member	4471 label Biography information for Rachael Maskell